GSE161052
The protective effect of spermine on diabetic cardiomyopathy.
Diabetic cardiomyopathy (DCM) is a specific form of cardiomyopathy that is independent of coronary artery disease and hypertension. Exploring the transcriptomics and proteomics of DCM is of great significance for understanding the biology of the disease and for guiding new therapeutic targets for the potential therapeutic effect of spermine (SPM). Overall design: The mRNA profiles of myocardial tissue of C57BL / 6 mice that divived into normal control group (CK), diabetic cardiomyopathy model group (DCM) and spermine treated group (SPM)